Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
PUT
Direxion Daily Small Cap Bear 3x ETF
TZA
$213M
| $1.34M | ﹤0.01% |
52
-38
| -42% | -$1.22M |
|
3027
Cullen/Frost Bankers
CFR
$10.3B
| $1.34M | ﹤0.01% |
18,044
-29,806
| -62% | -$2.13M |
|
3028
CALL
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$162M
| $1.34M | ﹤0.01% |
11,925
-7,500
| -39% | -$860K |
|
3029
Comfort Systems
FIX
$61.1B
| $1.34M | ﹤0.01% |
70,276
+32,589
| +86% | +$616K |
|
|
BCA
3030
DELISTED
CORPBANCA SPONSORED ADR REPSTG (1-1,500)COM STK
BCA
| $1.33M | ﹤0.01% |
63,481
+61,324
| +2,843% | +$1.12M |
|
|
TXI
3031
PUT
DELISTED
TEXAS INDUSTRIES INC
TXI
| $1.33M | ﹤0.01% |
19,600
-9,000
| -31% | -$529K |
|
|
CIT
3032
CALL
DELISTED
CIT Group Inc.
CIT
| $1.33M | ﹤0.01% |
25,600
+2,700
| +12% | +$134K |
|
3033
PUT
Waters Corp
WAT
$39.3B
| $1.33M | ﹤0.01% |
13,300
+5,400
| +68% | +$544K |
|
3034
BlackRock Floating Rate Income Strategies Fund
FRA
$384M
| $1.33M | ﹤0.01% |
94,967
+2,759
| +3% | +$40.2K |
|
3035
CALL
Direxion Daily Technology Bull 3x ETF
TECL
$6.02B
| $1.33M | ﹤0.01% |
730,000
+505,000
| +224% | +$783K |
|
|
DNR
3036
PUT
DELISTED
Denbury Resources, Inc.
DNR
| $1.33M | ﹤0.01% |
83,000
-39,500
| -32% | -$697K |
|
3037
Innospec
IOSP
$2.27B
| $1.33M | ﹤0.01% |
28,825
+2,608
| +10% | +$120K |
|
3038
BlackRock Enhanced International Dividend Trust
BGY
$526M
| $1.32M | ﹤0.01% |
+165,804
| New | +$1.32M |
|
3039
PUT
Alnylam Pharmaceuticals
ALNY
$30.6B
| $1.32M | ﹤0.01% |
20,600
-66,200
| -76% | -$3.95M |
|
|
CHS
3040
CALL
DELISTED
Chicos FAS, Inc.
CHS
| $1.32M | ﹤0.01% |
73,200
+23,500
| +47% | +$415K |
|
3041
MasTec
MTZ
$21.4B
| $1.32M | ﹤0.01% |
41,186
-178,405
| -81% | -$5.65M |
|
|
VTA
3042
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
| $1.31M | ﹤0.01% |
109,544
+36,082
| +49% | +$456K |
|
|
RSH
3043
PUT
DELISTED
RADIOSHACK CORP
RSH
| $1.31M | ﹤0.01% |
657,500
-30,400
| -4% | -$88.5K |
|
3044
PUT
NXP Semiconductors
NXPI
$58.3B
| $1.31M | ﹤0.01% |
+29,200
| New | +$1.2M |
|
3045
PTC
PTC
$15.1B
| $1.31M | ﹤0.01% |
37,522
-27,262
| -42% | -$837K |
|
|
SGMO
3046
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.31M | ﹤0.01% |
100,775
+88,552
| +724% | +$1.02M |
|
3047
Forum Energy Technologies
FET
$849M
| $1.31M | ﹤0.01% |
2,329
+921
| +65% | +$521K |
|
|
IVC
3048
DELISTED
Invacare Corporation
IVC
| $1.3M | ﹤0.01% |
56,779
+14,752
| +35% | +$305K |
|
3049
CALL
AB InBev
BUD
$168B
| $1.3M | ﹤0.01% |
12,300
-19,000
| -61% | -$1.94M |
|
|
CEQP
3050
DELISTED
Crestwood Equity Partners LP
CEQP
| $1.3M | ﹤0.01% |
10,007
+9,047
| +942% | +$1.29M |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.